Back

Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Aggressive ways of saving patients Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marah Hunjul

Nablus (Palestine, State of)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Takei (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Doctor T. Inamori (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Professor I. Sabirov (Bishkek, KG)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Aggressive ways of saving patients

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy
thumbnail
Congress Presentation
Comparative analysis of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor and mineralocorticoid receptor antagonists in heart failure with mildly reduced ejection fraction
thumbnail
Congress Presentation
MRAs in heart failure - An individual patient data meta-analysis of randomised trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources